SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18317064
Source:
http://linkedlifedata.com/resource/pubmed/id/18317064
Search
Subject
(
79
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0005940
,
umls-concept:C0029431
,
umls-concept:C0030705
,
umls-concept:C0036525
,
umls-concept:C0038952
,
umls-concept:C0205250
,
umls-concept:C0257685
,
umls-concept:C0441655
,
umls-concept:C0684249
,
umls-concept:C1522484
,
umls-concept:C2745888
pubmed:issue
3
pubmed:dateCreated
2008-3-4
pubmed:abstractText
Bone metastases from non-small cell lung cancer (NSCLC) are associated with skeletal-related events (SREs) and elevated levels of N-telopeptide of type I collagen (NTX) in some patients. Zoledronic acid (ZOL) reduces SRE risk and NTX levels.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18317064-18670319
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/101274235
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Alkaline Phosphatase
,
http://linkedlifedata.com/resource/pubmed/chemical/Bone Density Conservation Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type I
,
http://linkedlifedata.com/resource/pubmed/chemical/Diphosphonates
,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides
,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
,
http://linkedlifedata.com/resource/pubmed/chemical/collagen type I trimeric...
,
http://linkedlifedata.com/resource/pubmed/chemical/zoledronic acid
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1556-1380
pubmed:author
pubmed-author:BrownJanet EJE
,
pubmed-author:ColemanRobert ERE
,
pubmed-author:CookRichard JRJ
,
pubmed-author:HirshVeraV
,
pubmed-author:LangerCorey JCJ
,
pubmed-author:LiptonAllanA
,
pubmed-author:MajorPierre PPP
,
pubmed-author:SmithMatthew RMR
pubmed:issnType
Electronic
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
228-36
pubmed:dateRevised
2008-11-25
pubmed:meshHeading
pubmed-meshheading:18317064-Adult
,
pubmed-meshheading:18317064-Aged
,
pubmed-meshheading:18317064-Aged, 80 and over
,
pubmed-meshheading:18317064-Alkaline Phosphatase
,
pubmed-meshheading:18317064-Bone Density Conservation Agents
,
pubmed-meshheading:18317064-Bone Neoplasms
,
pubmed-meshheading:18317064-Canada
,
pubmed-meshheading:18317064-Carcinoma, Non-Small-Cell Lung
,
pubmed-meshheading:18317064-Collagen Type I
,
pubmed-meshheading:18317064-Diphosphonates
,
pubmed-meshheading:18317064-Enzyme-Linked Immunosorbent Assay
,
pubmed-meshheading:18317064-Female
,
pubmed-meshheading:18317064-Follow-Up Studies
,
pubmed-meshheading:18317064-Humans
,
pubmed-meshheading:18317064-Imidazoles
,
pubmed-meshheading:18317064-Lung Neoplasms
,
pubmed-meshheading:18317064-Male
,
pubmed-meshheading:18317064-Middle Aged
,
pubmed-meshheading:18317064-Osteoclasts
,
pubmed-meshheading:18317064-Peptides
,
pubmed-meshheading:18317064-Retrospective Studies
,
pubmed-meshheading:18317064-Time Factors
,
pubmed-meshheading:18317064-Treatment Outcome
,
pubmed-meshheading:18317064-Tumor Markers, Biological
,
pubmed-meshheading:18317064-United States
pubmed:year
2008
pubmed:articleTitle
Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity.
pubmed:affiliation
McGill University Health Centre, Montreal, Quebec, Canada. vera.hirsh@muhc.mcgill.ca
pubmed:publicationType
Journal Article
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study
,
Clinical Trial, Phase III